Sana Biotechnology (SANA) Retained Earnings (2020 - 2026)

Sana Biotechnology (SANA) posted Retained Earnings of $2.0 billion for Q1 2026, little changed sequentially from $2.0 billion in Q4 2025.

Sana Biotechnology (SANA) Retained Earnings (2020 - 2026) Analysis & Trends

Sana Biotechnology has reported Retained Earnings for 7 years, with the latest figure at $2.0 billion in Q1 2026.

Quarterly Retained Earnings changed N/A year-over-year to $2.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 billion (changed N/A YoY) and the FY2025 annual result came in at $2.0 billion, up 14355935.71% from the prior year.
Retained Earnings was little changed at $2.0 billion in Q1 2026 per SANA's latest filing, from $2.0 billion in the prior quarter.
Over five years, Retained Earnings peaked at $2.0 billion in Q1 2026 and troughed at -$1.8 billion in Q3 2025.
A 5-year average of $400.2 million and a median of $773.4 million in 2022 frame the typical range for Retained Earnings.
The sharpest annual moves came in 2022 and 2025: Retained Earnings plunged 48923.08% in 2022, then surged 14355935.71% in 2025.
Over 5 years, Retained Earnings stood at $1.6 billion in 2022, then climbed by 4.31% to $1.6 billion in 2023, then tumbled by 100.0% to $14000.0 in 2024, then soared by 14355935.71% to $2.0 billion in 2025, then increased by 0.28% to $2.0 billion in 2026.
According to Business Quant data, Retained Earnings over the past three periods registered $2.0 billion, $2.0 billion, and -$1.8 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Retained Earnings (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	15.69 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	37.62 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-4.00 Bn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	13.05 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-104.13 Mn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	4.38 Bn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-6.33 Bn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	6.57 Bn
10	Sana Biotechnology	1.06 Bn	1.06 Bn	-	2.11 Bn

Download Data